InsiderClue
Insiders · Profile

Bedrosian Camille L

Chief Medical Officer at Amylyx Pharmaceuticals · EVP and Chief Medical Officer at Ultragenyx Pharmaceutical. Filing since 14 Oct 2020. CIK 0001326969

AMLX Amylyx Pharmaceuticals, Inc. Chief Medical Officer · 7 trades RARE Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer · 12 trades
Company
Date
Role
Action
Shares
Amount
Of holding
AMLX Amylyx Pharmaceuticals, Inc.
10 Sep 2026
Chief Medical Officer
Sold at will
10,028
$324.87K
3.5%
AMLX Amylyx Pharmaceuticals, Inc.
2 Mar 2026
Chief Medical Officer
Sold at will
6,461
$94.21K
3.7%
AMLX Amylyx Pharmaceuticals, Inc.
1 Dec 2025
Chief Medical Officer
Sold at will
6,580
$94.42K
3.6%
AMLX Amylyx Pharmaceuticals, Inc.
30 Sep 2025
Chief Medical Officer
Sold at will
12,039
$175.52K
6.2%
AMLX Amylyx Pharmaceuticals, Inc.
31 Mar 2025
Chief Medical Officer
Sold at will
12,425
$43.08K
6.0%
AMLX Amylyx Pharmaceuticals, Inc.
2 Dec 2024
Chief Medical Officer
Sold at will
5,421
$30.01K
3.8%
AMLX Amylyx Pharmaceuticals, Inc.
30 Sep 2024
Chief Medical Officer
Sold at will
11,442
$36.56K
7.4%
RARE Ultragenyx Pharmaceutical Inc.
1 Mar 2023
EVP and Chief Medical Officer
Sold, plan not stated
3,881
$175.62K
7.7%
RARE Ultragenyx Pharmaceutical Inc.
1 Mar 2022
EVP and Chief Medical Officer
Sold, plan not stated
2,821
$187.94K
7.7%
RARE Ultragenyx Pharmaceutical Inc.
30 Jan 2022
EVP and Chief Medical Officer
Sold, plan not stated
1,657
$109.86K
4.3%
RARE Ultragenyx Pharmaceutical Inc.
14 Oct 2021
EVP and Chief Medical Officer
Sold, plan not stated
359
$29.13K
0.9%
RARE Ultragenyx Pharmaceutical Inc.
2 Sep 2021
EVP and Chief Medical Officer
Sold, plan not stated
2,500
$250.45K
6.1%
RARE Ultragenyx Pharmaceutical Inc.
1 Sep 2021
EVP and Chief Medical Officer
Sold, plan not stated
2,500
$250.08K
6.1%
RARE Ultragenyx Pharmaceutical Inc.
6 May 2021
EVP and Chief Medical Officer
Sold, plan not stated
364
$41.38K
0.9%
RARE Ultragenyx Pharmaceutical Inc.
15 Apr 2021
EVP and Chief Medical Officer
Sold, plan not stated
5,000
$545.45K
11.3%
RARE Ultragenyx Pharmaceutical Inc.
1 Mar 2021
EVP and Chief Medical Officer
Sold, plan not stated
4,543
$627.75K
10.4%
RARE Ultragenyx Pharmaceutical Inc.
30 Jan 2021
EVP and Chief Medical Officer
Sold, plan not stated
2,243
$314.83K
6.3%
RARE Ultragenyx Pharmaceutical Inc.
15 Jan 2021
EVP and Chief Medical Officer
Sold, plan not stated
25,000
$3.48M
41.1%
RARE Ultragenyx Pharmaceutical Inc.
14 Oct 2020
EVP and Chief Medical Officer
Sold, plan not stated
262
$23.06K
0.7%
19 decisions on file.